This study delineates the clinical and molecular features of PMP22 point mutations in Taiwan, expands the spectrum of PMP22 point mutations, and emphasizes its role in demyelinating CMT and HNPP-like neuropathy. The gene discussed is PMP22; the disease is hereditary neuropathy with liability to pressure palsies.